Abstract:Pediatric intracranial hypertension (ICH) syndrome is a critical and severe pathogenic disorder. An appropriate and effective treatment can reduce its mortality, and decrease incidences of secondary brain injuries and neurologic complications. Timely treatment of intracranial pressure is the key measure in the acute stage of pediatric ICH syndrome, and osmotic therapy is considered as the most common measure to reduce intracranial pressure. Osmotic drugs used in the acute stage of pediatric ICH syndrome include urea, glycerin, sorbitol, mannitol, and hypertonic saline, etc.. Since urea, glycerin and sorbitol are associated with numerous side effects, they are no longer used clinically. Mannitol as the traditionally used osmotic medication has a definitive effect on reducing intracranial pressure, thus it is still widely administrated in clinical practices. Despite that hypertonic saline has a similar effect on reduction of intracranial pressure as mannitol, continuous studies have shown that administration of hypertonic saline yields even better outcomes for reducing intracranial pressure and better maintenance of cerebral perfusion pressure (CPP) compared with the use of mannitol. Moreover, the administration of hypertonic saline may provide protection for brain functions through various mechanisms. From the perspective of protection for brain functions, new studies and guidelines increasingly suggest and pay attention to the application of hypertonic saline in reduction of intracranial pressure, especially, recommend it as the first-line osmotic medcine for traumatic brain injury (TBI)-induced pediatric ICH syndrome. As of today, questions are still remained: could hypertonic saline replace mannitol as the first-line osmotic medcine in reducing intracranial pressure or in which cases should hypertonic saline be preferably selected? This article focuses on the historical and current research progresses of osmotic therapy in reduction of intracranial pressure in the acute stage for children with ICH syndrome, and explores the mechanisms of reduction of intracranial pressure for mannitol and hypertonic saline, and discovers recent clinical status of using mannitol and hypertonic saline as well as comparison between these two medications in treatment of children with ICH syndrome. Key words: Intracranial hypertension; Intracranial pressure; Brain injuries; Mannitol; Saline solution, hypertonic; Osmotic therapy; Side effect; Child

Optimizing Mannitol Use in Managing Increased Intracranial Pressure: A Comprehensive Review of Recent Research and Clinical Experiences

[Comparison of Mannitol and Hypertonic Saline in Treatment of Intracranial Hypertension of Rabbits].

Mannitol in Critical Care and Surgery Over 50+ Years: A Systematic Review of Randomized Controlled Trials and Complications With Meta-Analysis

Understanding the physiological changes induced by mannitol: From the theory to the clinical practice in neuroanaesthesia

Should Hypertonic Saline Be Considered for the Treatment of Intracranial Hypertension? A Review of Current Evidence and Clinical Practices

Hypertonic saline versus mannitol for treatment of elevated intracranial pressure: a meta-analysis

Serial Assessment of Hemodynamic and Cerebrovascular Changes After Administration of Mannitol in Postoperative Neurosurgical Patients in the Intensive Care Unit: A Combined Transthoracic and Transcranial Color Doppler Study

Comparing the effects of mannitol and hypertonic saline in severe traumatic brain injury patients with elevated intracranial pressure: a systematic review and meta-analysis

Mannitol and Outcome in Intracerebral Hemorrhage

Application and Research of Osmotic Therapy in Children with Intracranial Hypertension Syndrome

Mannitol Cannot Reduce the Mortality on Acute Severe Traumatic Brain Injury (TBI) Patients: a Meta–analyses and Systematic Review

Transcranial Doppler Monitoring of Intracranial Pressure Therapy with Mannitol, Sorbitol and Glycerol in Patients with Acute Stroke

[Most effective daily dose and use method of mannitol in patients with cerebral hemorrhage at acute stage].

Multicentric prospective randomized controlled study of efficacy of mannitol,furosemide and albumin in reducing intracranial pressure in patients with severe brain injury

Hypertonic Saline and Mannitol in Patients with Traumatic Brain Injury

Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients

Mannitol Is Comparable to Hypertonic Saline for Raised Intracranial Pressure in Acute Liver Failure (MAHAL Study): A Randomized Controlled Trial

Evidence-Based Treatment for Increased Intracranial Pressure after Acute Traumatic Brain Injury

[The Role of Serum Osmolality Monitoring in Patients with Severe Intracranial Lesion].

New Insights on Mechanisms and Therapeutic Targets of Cerebral Edema

A comparative study on the efficacy of 10% hypertonic saline and equal volume of 20% mannitol in the treatment of experimentally induced cerebral edema in adult rats